KDM5C and cancer: Because proteolysis-targeting chimeras (PROTACs) are used to target and degrade proteins with important scaffolding functions and serve as a potential therapeutic strategy in cancer, future work focusing on the design and synthesis of KDM5C PROTAC drugs is important, and further studies in this research direction are warranted.